The start of 2022 has been anything but plain sailing for investors, with Russia’s invasion of Ukraine unleashing further volatility on markets already grappling with soaring inflation and rapidly shifting central bank policies.
- Home
- Uncategorised
- Wise Funds: Biotech bargains offer buying opportunity amid volatile markets